Neogen/$NEOG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neogen
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
Ticker
$NEOG
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,917
ISIN
US6404911066
Website
Neogen Metrics
BasicAdvanced
$1.1B
-
-$2.24
1.57
-
Price and volume
Market cap
$1.1B
Beta
1.57
52-week high
$18.58
52-week low
$3.87
Average daily volume
5.4M
Financial strength
Current ratio
3.907
Quick ratio
2.038
Long term debt to equity
33.477
Total debt to equity
33.614
Interest coverage (TTM)
0.52%
Profitability
EBITDA (TTM)
158.781
Gross margin (TTM)
48.79%
Net profit margin (TTM)
-53.56%
Operating margin (TTM)
4.49%
Effective tax rate (TTM)
4.53%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
0.59%
Return on equity (TTM)
-16.71%
Valuation
Price to revenue (TTM)
1.165
Price to book
0.4
Price to tangible book (TTM)
-2.35
Price to free cash flow (TTM)
-23.851
Free cash flow yield (TTM)
-4.19%
Free cash flow per share (TTM)
-20.42%
Growth
Revenue change (TTM)
-2.50%
Earnings per share change (TTM)
-31,043.17%
3-year revenue growth (CAGR)
20.76%
10-year revenue growth (CAGR)
12.80%
3-year earnings per share growth (CAGR)
69.87%
10-year earnings per share growth (CAGR)
21.52%
What the Analysts think about Neogen
Analyst ratings (Buy, Hold, Sell) for Neogen stock.
Bulls say / Bears say
Neogen's successful refinancing of its $450 million term loan and expansion of its revolving credit facility to $250 million, with improved terms, enhances financial flexibility and reduces interest expenses. (stocktitan.net)
Significant insider purchases, including CEO John Adent acquiring 23,035 shares and CFO David Naemura purchasing 14,800 shares, signal strong confidence in the company's future prospects. (americanbankingnews.com)
Institutional investors like Barclays PLC increasing their stake in Neogen by 29.6% to $5.77 million indicates growing institutional confidence in the company's potential. (marketbeat.com)
Neogen reported a net loss of $11.0 million in Q3 2025, with revenues declining by 3.4% year-over-year, reflecting operational challenges and market pressures. (stocktitan.net)
The company faced a substantial net loss of $456.3 million in Q2 2025, primarily due to a non-cash goodwill impairment charge related to the acquisition of the former 3M Food Safety Division, raising concerns about acquisition integration. (tradingview.com)
Neogen's Q1 2025 revenues decreased by 5.3% year-over-year, with a net loss of $12.6 million, indicating ongoing financial struggles and potential market share erosion. (tradingview.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
Neogen Financial Performance
Revenues and expenses
Neogen Earnings Performance
Company profitability
Neogen News
AllArticlesVideos
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Business Wire·22 hours ago
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Business Wire·3 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
GlobeNewsWire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neogen stock?
Neogen (NEOG) has a market cap of $1.1B as of June 26, 2025.
What is the P/E ratio for Neogen stock?
The price to earnings (P/E) ratio for Neogen (NEOG) stock is 0 as of June 26, 2025.
Does Neogen stock pay dividends?
No, Neogen (NEOG) stock does not pay dividends to its shareholders as of June 26, 2025.
When is the next Neogen dividend payment date?
Neogen (NEOG) stock does not pay dividends to its shareholders.
What is the beta indicator for Neogen?
Neogen (NEOG) has a beta rating of 1.57. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.